<html>
  <head>
    <title>
</title></head>
  <body bgcolor="#ffffff"><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman"><strong>UNITED
      STATES </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman"><strong>SECURITIES
      AND EXCHANGE COMMISSION </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Washington,
      D.C. 20549 </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman"><strong>FORM
      8-K</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CURRENT
      REPORT </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Pursuant
      to Section 13 OR 15(d) of the </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Securities
      Exchange Act of 1934 </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date
      of
      Report (Date of earliest event reported): June 19, 2006 </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ADVANCE
      NANOTECH, INC. </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Exact
      name of registrant as specified in its charter) </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">

          <tr bgcolor="white">
            <td width="30%" style="border-bottom: black thin solid;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><strong><font size="2">Delaware</font></strong></div>
            </td>
            <td width="5%" style="border-bottom: #ffffff solid;">&#160;</td>
            <td width="30%" style="border-bottom: black thin solid;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><strong><font size="2">011-15499</font></strong></div>
            </td>
            <td width="5%" style="border-bottom: #ffffff solid;">&#160;</td>
            <td width="30%" style="border-bottom: black thin solid;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><strong><font size="2">20-1614256</font></strong></div>
            </td>
          </tr>
          <tr bgcolor="white">
            <td width="30%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font size="2">(State
                or other jurisdiction</font></div>
            </td>
            <td width="5%">&#160;</td>
            <td width="30%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font size="2">(Commission</font></div>
            </td>
            <td width="5%">&#160;</td>
            <td width="30%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font size="2">(I.R.S.
                Employer</font></div>
            </td>
          </tr>
          <tr bgcolor="white">
            <td width="30%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font size="2">of
                incorporation)</font></div>
            </td>
            <td width="5%">&#160;</td>
            <td width="30%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font size="2">File
                Number)</font></div>
            </td>
            <td width="5%">&#160;</td>
            <td width="30%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font size="2">Identification
                No.)</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div align="center">&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">

          <tr bgcolor="white">
            <td width="50%" style="border-bottom: black thin solid;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><strong><font size="2">600
                Lexington Avenue, 29th Floor, New
                York, NY</font></strong></div>
            </td>
            <td width="5%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td width="45%" style="border-bottom: black thin solid;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><strong><font size="2">10022</font></strong></div>
            </td>
          </tr>
          <tr bgcolor="white">
            <td width="50%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font size="2">(Address
                of principal executive
                offices)</font></div>
            </td>
            <td width="5%">&#160;</td>
            <td width="45%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font size="2">(Zip
                Code)</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Registrant's
      telephone number, including area code: </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>(212)
      583-0080</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not
      Applicable </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Former
      name or former address, if changed since last report) </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Check
      the
      appropriate box below if the Form 8-K filing is intended to simultaneously
      satisfy the filing obligation of the registrant under any of the following
      provisions (see General Instruction A.2. below): </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">o</font></font></div>
            </td>
            <td align="left" valign="top" width="77%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Written
                communications pursuant to Rule 425 under the Securities Act (17
                CFR
                230.425) </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">o</font></font>&#160;</div>
              </div>
            </td>
            <td align="left" valign="top" width="77%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Soliciting
                material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
                240.14a-12) </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">o</font></font>&#160;</div>
              </div>
            </td>
            <td align="left" valign="top" width="77%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pre-commencement
                communications pursuant to Rule 14d-2(b) under the Exchange Act (17
                CFR
                240.14d-2(b)) </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">o</font></font>&#160;</div>
              </div>
            </td>
            <td align="left" valign="top" width="77%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pre-commencement
                communications pursuant to Rule 13e-4(c) under the Exchange Act (17
                CFR
                240.13e-4(c)) </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Item
      3.03 Material Modification to Rights of Security Holders.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
      June
      19, 2006, Advance Nanotech, Inc., a Colorado corporation ("Advance Nanotech
      Colorado"), merged with and into its newly-formed, wholly owned subsidiary,
      Advance Nanotech, Inc., a Delaware corporation ("Advance Nanotech Delaware")
      in
      order to reincorporate in the State of Delaware (the "Reincorporation Merger").
      The Reincorporation Merger was affected pursuant to a Certificate of Ownership
      and Merger entered into among Advance Nanotech Colorado and Advance Nanotech
      Delaware. The Reincorporation Merger was submitted to a vote of, and approved
      by, Advance Nanotech Colorado's shareholders at its Annual Meeting held on
      May
      11, 2006. As a result of the Reincorporation Merger, the legal domicile of
      Advance Nanotech, Inc. (OTC BB: &#8220;AVNA.OB&#8221;) (the &#8220;Company&#8221;) is now
      Delaware.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
      provided by the Certificate of Ownership and Merger, each outstanding Advance
      Nanotech Colorado common share ("Colorado Common Stock"), was automatically
      converted into one Advance Nanotech Delaware common share ("Delaware Common
      Stock"), at the time the Reincorporation Merger became effective. Each share
      certificate representing issued and outstanding Colorado Common Stock continues
      to represent the same number of shares of Delaware Common Stock. In addition,
      as
      a result of the Reincorporation Merger, each outstanding option, right or
      warrant to acquire shares of Colorado Common Stock converted into an option,
      right or warrant to acquire an equal number of shares of Delaware Common Stock,
      with no further action required by any party, under the same terms and
      conditions as the original option, right or warrant, and such options, rights
      and warrants shall no longer represent the right to acquire shares of Colorado
      Common Stock.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
      to the Agreement and Plan of Merger, the directors and officers of Advance
      Nanotech Colorado in office immediately prior to the Reincorporation Merger
      continue to serve as the directors and officers of the Company. None of the
      Company's subsidiaries changed its respective state or jurisdiction of
      incorporation in connection with the Reincorporation Merger, although the
      Company&#8217;s previously existing Delaware subsidiary with the name Advance
      Nanotech, Inc. changed its name to &#8220;Advance Nanotech Holdings, Inc.&#8221; The
      Company's common stock continues to be quoted on the OTC: BB under the symbol
      "AVNA.OB". </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prior
      to
      the Reincorporation Merger, the Company's corporate affairs were governed by
      the
      corporate law of Colorado, and Advance Nanotech Colorado&#8217;s Articles of
      Incorporation and Bylaws (the "Colorado Charter and Bylaws"), each of which
      were
      adopted under Colorado law. Pursuant to the Certificate of Ownership and Merger
      described above, and as a result of the consummation of the Reincorporation
      Merger, the Certificate of Incorporation and the Bylaws of Advance
      Nanotech</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      Delaware
      in effect immediately prior to the consummation of the Reincorporation Merger
      (the "Delaware Charter and Bylaws") became the Certificate of Incorporation
      and
      Bylaws of the surviving Delaware corporation, Advance Nanotech Delaware.
      Accordingly, the constituent instruments defining the rights of holders of
      the
      Company's common stock will now be the Delaware Charter and Bylaws rather than
      the Colorado Charter and Bylaws. Additionally, as a result of the
      Reincorporation Merger, Delaware corporate law will generally be applicable
      in
      the determination of the rights of stockholders of the Company under State
      corporate laws. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Delaware Charter creates a class of "blank check" preferred stock, par value
      $0.001 per share, consisting of 25,000,000 shares. The term "blank check"
      preferred stock refers to stock for which the designations, preferences,
      conversion rights, and cumulative, relative, participating, optional or other
      rights, including voting rights, qualifications, limitations or restrictions
      thereof, are determined by the Board of Directors (&#8220;Board&#8221;) of a company. As
      such, the Board will be entitled to authorize the creation and issuance of
      25,000,000 shares of preferred stock in one or more series with such limitations
      and restrictions as may be determined in the sole discretion of the Board,
      with
      no further authorization by stockholders required for the creation and issuance
      of the preferred stock. Any preferred stock issued would have priority over
      the
      common stock upon liquidation and might have priority rights as to dividends,
      voting and other features. Accordingly, the issuance of preferred stock could
      decrease the amount of earnings and assets allocable to or available for
      distribution to holders of common stock and adversely affect the rights and
      powers, including voting rights, of the common stock.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: -36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      foregoing is a general description only and is subject to the detailed terms
      and
      conditions, and is qualified in its entirety by reference, to the Agreement
      and
      Plan of Merger, attached as Exhibit&#160;2.1, Advance Nanotech Delaware&#8217;s
      Certificate of Incorporation, attached as Exhibit&#160;3.1, and Bylaws of
      Advance Nanotech Delaware, attached as Exhibit&#160;3.2. A copy of the press
      release announcing the Reincorporation Merger is attached hereto as
      Exhibit&#160;99.1 and is furnished but not filed for purposes of Section 18
      under the Securities Exchange Act of 1934.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ITEM
      5.03 Amendments to Articles of Incorporation or Bylaws.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">See
      Item
      3.03 of this Report on Form 8-K.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Item
      9.01. Financial Statements and Exhibits. </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      following </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">exhibits
      are</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      included
      as part of this report: </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
      Exhibits. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">

          <tr bgcolor="white">
            <td width="6%" style="border-bottom: black thin solid;"><a name="fis_unidentified_table_2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No.</font></a></td>
            <td width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
            <td width="92%" style="border-bottom: black thin solid;"><font size="2">Description</font></td>
          </tr>
          <tr bgcolor="white">
            <td width="6%">&#160;</td>
            <td width="2%">&#160;</td>
            <td width="92%">&#160;</td>
          </tr>
          <tr bgcolor="white">
            <td width="6%"><font size="2">2.1</font></td>
            <td width="2%">&#160;</td>
            <td width="92%"><font size="2">Agreement and Plan of Merger dated as
              of May
              11, 2006, by and between Advance Nanotech Inc., a Colorado Corporation
              and
              Advance Nanotech Inc., a Delaware Corporation.<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></font></td>
          </tr>
          <tr bgcolor="white">
            <td width="6%">&#160;</td>
            <td width="2%">&#160;</td>
            <td width="92%">&#160;</td>
          </tr>
          <tr bgcolor="white">
            <td width="6%"><font size="2">3.1</font></td>
            <td width="2%">&#160;</td>
            <td width="92%"><font size="2">Certificate of Incorporation of the
              Registrant under the laws of the State of Delaware<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></font></td>
          </tr>
          <tr bgcolor="white">
            <td width="6%">&#160;</td>
            <td width="2%">&#160;</td>
            <td width="92%">&#160;</td>
          </tr>
          <tr bgcolor="white">
            <td width="6%"><font size="2">3.2</font></td>
            <td width="2%">&#160;</td>
            <td width="92%"><font size="2">Bylaws of <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Advance
              Nanotech Inc., a Delaware Corporation.</font></font></td>
          </tr>
          <tr bgcolor="white">
            <td width="6%">&#160;</td>
            <td width="2%">&#160;</td>
            <td width="92%">&#160;</td>
          </tr>
          <tr bgcolor="white">
            <td width="6%"><font size="2">99.1</font></td>
            <td width="2%">&#160;</td>
            <td width="92%"><font size="2">Press release dated June 20, 2006.<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
              (furnished but not filed for purposes of Section 18 under the Securities
              Exchange Act of 1934)</font></font></td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SIGNATURES
      </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
      to the requirements of the Securities Exchange Act of 1934, the registrant
      has
      duly caused this report to be signed on its behalf by the undersigned hereunto
      duly authorized. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <table align="center" bgcolor="#ffffff" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr valign="top" bgcolor="#ffffff">
            <td width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
            <td width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
            <td width="49%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
            <td colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: "><strong>ADVANCE
              NANOTECH, INC. </strong></font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td>&#160;</td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: "><em>By:</em>&#160;&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">/s/&#160;<em>Magnus
              R. E. Gittins</em></font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td colspan="2"><font style="FONT-FAMILY: " size="1">&#160;</font></td>
            <td align="left">
              <hr style="COLOR: black" align="left" noshade size="2" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Magnus
                R. E. Gittins</em></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Chief
                Executive Officer</em></font></div>
            </td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td colspan="2">&#160;</td>
            <td>&#160;</td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">Dated:
              June 20,
              2006 </font></td>
            <td>&#160;</td>
          </tr>

      </table>
    </div>
  </body>
</html>
{"company-data": {"conformed-name": "Advance Nanotech, Inc.", "cik": "0000354699", "assigned-sic": "6799", "irs-number": "840820529", "state-of-incorporation": "CO", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-10065", "film-number": "06915107"}, "business-address": {"street1": "600 LEXINGTON AVENUE", "street2": "29TH FLOOR", "city": "NEW YORK", "state": "NY", "zip": "10022", "phone": "(212) 583-0080"}, "mail-address": {"street1": "600 LEXINGTON AVENUE", "street2": "29TH FLOOR", "city": "NEW YORK", "state": "NY", "zip": "10022"}, "former-company": [{"former-conformed-name": "DYNAMIC I-T INC", "date-changed": "19990830"}, {"former-conformed-name": "COLORADO GOLD & SILVER INC", "date-changed": "19920703"}]}
UNITED
      STATES
SECURITIES
      AND EXCHANGE COMMISSION
Washington,
      D.C. 20549
FORM
      8-K
CURRENT
      REPORT
Pursuant
      to Section 13 OR 15(d) of the
Securities
      Exchange Act of 1934
Date
      of
      Report (Date of earliest event reported): June 19, 2006
ADVANCE
      NANOTECH, INC.
(Exact
      name of registrant as specified in its charter)
Delaware
011-15499
20-1614256
(State
                or other jurisdiction
(Commission
(I.R.S.
                Employer
of
                incorporation)
File
                Number)
Identification
                No.)
600
                Lexington Avenue, 29th Floor, New
                York, NY
10022
(Address
                of principal executive
                offices)
(Zip
                Code)
Registrant's
      telephone number, including area code:
(212)
      583-0080
Not
      Applicable
(Former
      name or former address, if changed since last report)
Check
      the
      appropriate box below if the Form 8-K filing is intended to simultaneously
      satisfy the filing obligation of the registrant under any of the following
      provisions (see General Instruction A.2. below):
o
Written
                communications pursuant to Rule 425 under the Securities Act (17
                CFR
                230.425)
o
Soliciting
                material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
                240.14a-12)
o
Pre-commencement
                communications pursuant to Rule 14d-2(b) under the Exchange Act (17
                CFR
                240.14d-2(b))
o
Pre-commencement
                communications pursuant to Rule 13e-4(c) under the Exchange Act (17
                CFR
                240.13e-4(c))
Item
      3.03 Material Modification to Rights of Security Holders.
On
      June
      19, 2006, Advance Nanotech, Inc., a Colorado corporation ("Advance Nanotech
      Colorado"), merged with and into its newly-formed, wholly owned subsidiary,
      Advance Nanotech, Inc., a Delaware corporation ("Advance Nanotech Delaware")
      in
      order to reincorporate in the State of Delaware (the "Reincorporation Merger").
      The Reincorporation Merger was affected pursuant to a Certificate of Ownership
      and Merger entered into among Advance Nanotech Colorado and Advance Nanotech
      Delaware. The Reincorporation Merger was submitted to a vote of, and approved
      by, Advance Nanotech Colorado's shareholders at its Annual Meeting held on
      May
      11, 2006. As a result of the Reincorporation Merger, the legal domicile of
      Advance Nanotech, Inc. (OTC BB: "AVNA.OB") (the "Company") is now
      Delaware.
As
      provided by the Certificate of Ownership and Merger, each outstanding Advance
      Nanotech Colorado common share ("Colorado Common Stock"), was automatically
      converted into one Advance Nanotech Delaware common share ("Delaware Common
      Stock"), at the time the Reincorporation Merger became effective. Each share
      certificate representing issued and outstanding Colorado Common Stock continues
      to represent the same number of shares of Delaware Common Stock. In addition,
      as
      a result of the Reincorporation Merger, each outstanding option, right or
      warrant to acquire shares of Colorado Common Stock converted into an option,
      right or warrant to acquire an equal number of shares of Delaware Common Stock,
      with no further action required by any party, under the same terms and
      conditions as the original option, right or warrant, and such options, rights
      and warrants shall no longer represent the right to acquire shares of Colorado
      Common Stock.
Pursuant
      to the Agreement and Plan of Merger, the directors and officers of Advance
      Nanotech Colorado in office immediately prior to the Reincorporation Merger
      continue to serve as the directors and officers of the Company. None of the
      Company's subsidiaries changed its respective state or jurisdiction of
      incorporation in connection with the Reincorporation Merger, although the
      Company's previously existing Delaware subsidiary with the name Advance
      Nanotech, Inc. changed its name to "Advance Nanotech Holdings, Inc." The
      Company's common stock continues to be quoted on the OTC: BB under the symbol
      "AVNA.OB".
Prior
      to
      the Reincorporation Merger, the Company's corporate affairs were governed by
      the
      corporate law of Colorado, and Advance Nanotech Colorado's Articles of
      Incorporation and Bylaws (the "Colorado Charter and Bylaws"), each of which
      were
      adopted under Colorado law. Pursuant to the Certificate of Ownership and Merger
      described above, and as a result of the consummation of the Reincorporation
      Merger, the Certificate of Incorporation and the Bylaws of Advance
      Nanotech
Delaware
      in effect immediately prior to the consummation of the Reincorporation Merger
      (the "Delaware Charter and Bylaws") became the Certificate of Incorporation
      and
      Bylaws of the surviving Delaware corporation, Advance Nanotech Delaware.
      Accordingly, the constituent instruments defining the rights of holders of
      the
      Company's common stock will now be the Delaware Charter and Bylaws rather than
      the Colorado Charter and Bylaws. Additionally, as a result of the
      Reincorporation Merger, Delaware corporate law will generally be applicable
      in
      the determination of the rights of stockholders of the Company under State
      corporate laws.
The
      Delaware Charter creates a class of "blank check" preferred stock, par value
      $0.001 per share, consisting of 25,000,000 shares. The term "blank check"
      preferred stock refers to stock for which the designations, preferences,
      conversion rights, and cumulative, relative, participating, optional or other
      rights, including voting rights, qualifications, limitations or restrictions
      thereof, are determined by the Board of Directors ("Board") of a company. As
      such, the Board will be entitled to authorize the creation and issuance of
      25,000,000 shares of preferred stock in one or more series with such limitations
      and restrictions as may be determined in the sole discretion of the Board,
      with
      no further authorization by stockholders required for the creation and issuance
      of the preferred stock. Any preferred stock issued would have priority over
      the
      common stock upon liquidation and might have priority rights as to dividends,
      voting and other features. Accordingly, the issuance of preferred stock could
      decrease the amount of earnings and assets allocable to or available for
      distribution to holders of common stock and adversely affect the rights and
      powers, including voting rights, of the common stock.
The
      foregoing is a general description only and is subject to the detailed terms
      and
      conditions, and is qualified in its entirety by reference, to the Agreement
      and
      Plan of Merger, attached as Exhibit 2.1, Advance Nanotech Delaware's
      Certificate of Incorporation, attached as Exhibit 3.1, and Bylaws of
      Advance Nanotech Delaware, attached as Exhibit 3.2. A copy of the press
      release announcing the Reincorporation Merger is attached hereto as
      Exhibit 99.1 and is furnished but not filed for purposes of Section 18
      under the Securities Exchange Act of 1934.
ITEM
      5.03 Amendments to Articles of Incorporation or Bylaws.
See
      Item
      3.03 of this Report on Form 8-K.
Item
      9.01. Financial Statements and Exhibits.
The
      following
exhibits
      are
included
      as part of this report:
(d)
      Exhibits.
No.
Description
2.1
Agreement and Plan of Merger dated as
              of May
              11, 2006, by and between Advance Nanotech Inc., a Colorado Corporation
              and
              Advance Nanotech Inc., a Delaware Corporation.
3.1
Certificate of Incorporation of the
              Registrant under the laws of the State of Delaware
.
3.2
Bylaws of
Advance
              Nanotech Inc., a Delaware Corporation.
99.1
Press release dated June 20, 2006.
(furnished but not filed for purposes of Section 18 under the Securities
              Exchange Act of 1934)
SIGNATURES
Pursuant
      to the requirements of the Securities Exchange Act of 1934, the registrant
      has
      duly caused this report to be signed on its behalf by the undersigned hereunto
      duly authorized.
ADVANCE
              NANOTECH, INC.
By:
/s/
Magnus
              R. E. Gittins
Magnus
                R. E. Gittins
Chief
                Executive Officer
Dated:
              June 20,
              2006